These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 25073678)

  • 1. Evaluation of a closed-system cytotoxic transfer device in a pharmaceutical isolator.
    Vyas N; Turner A; Clark JM; Sewell GJ
    J Oncol Pharm Pract; 2016 Feb; 22(1):10-9. PubMed ID: 25073678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Environmental contamination with cytotoxic drugs in healthcare using positive air pressure isolators.
    Crauste-Manciet S; Sessink PJ; Ferrari S; Jomier JY; Brossard D
    Ann Occup Hyg; 2005 Oct; 49(7):619-28. PubMed ID: 16126757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Environmental contamination by cyclophosphamide preparation: Comparison of conventional manual production in biological safety cabinet and robot-assisted production by APOTECAchemo.
    Schierl R; Masini C; Groeneveld S; Fischer E; Böhlandt A; Rosini V; Paolucci D
    J Oncol Pharm Pract; 2016 Feb; 22(1):37-45. PubMed ID: 25227229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing workplace cytotoxic surface contamination using a closed-system drug transfer device.
    Siderov J; Kirsa S; McLauchlan R
    J Oncol Pharm Pract; 2010 Mar; 16(1):19-25. PubMed ID: 19965949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exposure to antineoplastic drugs in two UK hospital pharmacy units.
    Mason HJ; Blair S; Sams C; Jones K; Garfitt SJ; Cuschieri MJ; Baxter PJ
    Ann Occup Hyg; 2005 Oct; 49(7):603-10. PubMed ID: 15964878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a closed system drug-transfer device eliminates surface contamination with antineoplastic agents.
    Clark BA; Sessink PJ
    J Oncol Pharm Pract; 2013 Jun; 19(2):99-104. PubMed ID: 23292973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter evaluation of a new closed system drug-transfer device in reducing surface contamination by antineoplastic hazardous drugs.
    Bartel SB; Tyler TG; Power LA
    Am J Health Syst Pharm; 2018 Feb; 75(4):199-211. PubMed ID: 29339374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occupational exposure to anti-cancer drugs: A review of effects of new technology.
    Vyas N; Yiannakis D; Turner A; Sewell GJ
    J Oncol Pharm Pract; 2014 Aug; 20(4):278-87. PubMed ID: 23975555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environmental contamination, product contamination and workers exposure using a robotic system for antineoplastic drug preparation.
    Sessink PJ; Leclercq GM; Wouters DM; Halbardier L; Hammad C; Kassoul N
    J Oncol Pharm Pract; 2015 Apr; 21(2):118-27. PubMed ID: 24567041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Environmental and biological monitoring of platinum-containing drugs in two hospital pharmacies using positive air pressure isolators.
    Kopp B; Crauste-Manciet S; Guibert A; Mourier W; Guerrault-Moro MN; Ferrari S; Jomier JY; Brossard D; Schierl R
    Ann Occup Hyg; 2013 Apr; 57(3):374-83. PubMed ID: 23091112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact and appreciation of two methods aiming at reducing hazardous drug environmental contamination: The centralization of the priming of IV tubing in the pharmacy and use of a closed-system transfer device.
    Guillemette A; Langlois H; Voisine M; Merger D; Therrien R; Mercier G; Lebel D; Bussières JF
    J Oncol Pharm Pract; 2014 Dec; 20(6):426-32. PubMed ID: 24395542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PhaSeal® system: impact of its use on workplace contamination and duration of chemotherapy preparation.
    Favier B; Labrosse H; Gilles-Afchain L; Cropet C; Perol D; Chaumard N; Latour JF; Hild P
    J Oncol Pharm Pract; 2012 Mar; 18(1):37-45. PubMed ID: 21422148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a closed system device to reduce occupational contamination and exposure to antineoplastic drugs in the hospital work environment.
    Yoshida J; Tei G; Mochizuki C; Masu Y; Koda S; Kumagai S
    Ann Occup Hyg; 2009 Mar; 53(2):153-60. PubMed ID: 19261696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative parallel assessment of a transfer device in reducing 5-fluorouracil environmental contamination inside positive air pressure isolators.
    Forges F; Simoens X; Chauvin F
    J Oncol Pharm Pract; 2011 Mar; 17(1):61-7. PubMed ID: 20699332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction in surface contamination with antineoplastic drugs in 22 hospital pharmacies in the US following implementation of a closed-system drug transfer device.
    Sessink PJ; Connor TH; Jorgenson JA; Tyler TG
    J Oncol Pharm Pract; 2011 Mar; 17(1):39-48. PubMed ID: 20156932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding.
    Soefje S; Rickabaugh K; Rajkumar R; Wall KP
    Int J Pharm Compd; 2021; 25(6):515-522. PubMed ID: 34807847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of surface contamination with cyclophosphamide and fluorouracil using a closed-system drug transfer device versus standard preparation techniques.
    Harrison BR; Peters BG; Bing MR
    Am J Health Syst Pharm; 2006 Sep; 63(18):1736-44. PubMed ID: 16960258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding.
    Soefje S; Rickabaugh K; Rajkumar R; Wall KP
    Int J Pharm Compd; 2022; 26(1):72-79. PubMed ID: 35081047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot assessment of the antineoplastic drug contamination levels in British Columbian hospitals pre- and post-cleaning.
    Chu WC; Hon CY; Danyluk Q; Chua PP; Astrakianakis G
    J Oncol Pharm Pract; 2012 Mar; 18(1):46-51. PubMed ID: 21737485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The assessment of environmental and external cross-contamination in preparing ready-to-administer cytotoxic drugs: a comparison between a robotic system and conventional manual production.
    Werumeus Buning A; Geersing TH; Crul M
    Int J Pharm Pract; 2020 Feb; 28(1):66-74. PubMed ID: 31489970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.